It was our pleasure to share some thoughts on being a diagnostic startup and what we think the future holds for Bioarray.

“At Bioarray, we want to eliminate the error  and fear inherent in cancer treatment by combining gene profiling with machine learning algorithms to identify the best treatment option for a patient to achieve remission of their cancer.” Marcia Fournier

BioarrayGenetics18M-CEOCFOMagazine

2018-09-25T03:50:21+00:00